Literature DB >> 1990841

Molecular genetic basis of maple syrup urine disease in a family with two defective alleles for branched chain acyltransferase and localization of the gene to human chromosome 1.

W J Herring1, S Litwer, J L Weber, D J Danner.   

Abstract

Maple syrup urine disease in humans results from inherited defects in branched chain alpha-ketoacid dehydrogenase, a mitochondrial multienzyme complex. A variety of genetic changes may produce this phenotype by affecting the function of any of the three complex-specific subunits. The varied clinical expression observed in patients may be partially explained by the defects in the involved subunit. Here we report localization of the gene for the branched chain acyltransferase component of the complex to human chromosome 1 and describe a proband who is a compound heterozygote at this locus. One allele, inherited from the father, produces transcripts with 124 nucleotides deleted from the coding region. The deletion is not found in the branched chain acyltransferase gene, implying that the deleted transcripts arise by an error in transcript processing. Cells from the patient's mother contain 50% of the normal amount of mRNA for the subunit, and the proband has inherited this nonexpressing allele from her. As a result, the proband produces no acyltransferase protein and therefore has greatly impaired complex activity. A phenotypically normal sibling is shown to be genetically similar to the mother having inherited the mother's nonexpressing allele and the father's normal allele.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1990841      PMCID: PMC1683011     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Lowry determination of protein in the presence of Triton X-100.

Authors:  C Wang; R L Smith
Journal:  Anal Biochem       Date:  1975-02       Impact factor: 3.365

2.  A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance.

Authors:  J H MENKES; P L HURST; J M CRAIG
Journal:  Pediatrics       Date:  1954-11       Impact factor: 7.124

3.  Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells.

Authors:  N M Gough
Journal:  Anal Biochem       Date:  1988-08-15       Impact factor: 3.365

4.  Cloning and cDNA sequence of the dihydrolipoamide dehydrogenase component human alpha-ketoacid dehydrogenase complexes.

Authors:  G Pons; C Raefsky-Estrin; D J Carothers; R A Pepin; A A Javed; B W Jesse; M K Ganapathi; D Samols; M S Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  The cytosolic factor required for import of precursors of mitochondrial proteins into mitochondria.

Authors:  H Ono; S Tuboi
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

6.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

7.  Synthesis and intracellular transport of mitochondrial matrix proteins in rat liver: studies in vivo and in vitro.

Authors:  G C Shore; R A Rachubinski; C Argan; R Rozen; M Pouchelet; C J Lusty; Y Raymond
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

9.  A synthetic signal peptide blocks import of precursor proteins destined for the mitochondrial inner membrane or matrix.

Authors:  L L Gillespie; C Argan; A T Taneja; R S Hodges; K B Freeman; G C Shore
Journal:  J Biol Chem       Date:  1985-12-25       Impact factor: 5.157

10.  Gene for lipoamide dehydrogenase maps to human chromosome 7.

Authors:  G Otulakowski; B H Robinson; H F Willard
Journal:  Somat Cell Mol Genet       Date:  1988-07
View more
  7 in total

1.  A simple method to confirm and size deletion, duplication, and insertion mutations detected by sequence analysis.

Authors:  Lawrence N Hjelm; Ephrem L H Chin; Madhuri R Hegde; Bradford W Coffee; Lora J H Bean
Journal:  J Mol Diagn       Date:  2010-07-15       Impact factor: 5.568

2.  The management of pregnancy in maple syrup urine disease: experience with two patients.

Authors:  Michel Tchan; M Westbrook; G Wilcox; R Cutler; N Smith; R Penman; B J G Strauss; B Wilcken
Journal:  JIMD Rep       Date:  2013-02-14

Review 3.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Maple syrup urine disease (MSUD): screening for known mutations in Italian patients.

Authors:  T Parrella; S Surrey; A Iolascon; M Sartore; R Heidenreich; G Diamond; A Ponzone; O Guardamagna; A B Burlina; R Cerone
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.

Authors:  C W Fisher; C R Fisher; J L Chuang; K S Lau; D T Chuang; R P Cox
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

6.  Genomic and biochemical analysis of repeatedly observed variants in DBT in individuals with maple syrup urine disease of Central American ancestry.

Authors:  Charles J Billington; Kimberly A Chapman; Eyby Leon; Beatrix W Meltzer; Seth I Berger; Matthew Olson; Robert A Figler; Steve A Hoang; Cui Wanxing; Brian R Wamhoff; M Sol Collado; Kristina Cusmano-Ozog
Journal:  Am J Med Genet A       Date:  2022-07-07       Impact factor: 2.578

7.  Identification of novel mutations in BCKDHB and DBT genes in Vietnamese patients with maple sirup urine disease.

Authors:  Thi T N Nguyen; Chi D Vu; Ngoc L Nguyen; Thi T H Nguyen; Ngoc K Nguyen; Huy H Nguyen
Journal:  Mol Genet Genomic Med       Date:  2020-06-09       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.